Back to company

PHARMA EVIDENCE ApS: Financial statements 2017

CVR: 34586519

PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 625,347 and a net result of DKK 279,719 compared with DKK -47,525 the year before. Equity amounted to DKK 305,566. The solvency ratio was 53.2%. The company had 1 employee in the financial year.

Gross Profit
625,347 kr.
Profit/Loss
279,719 kr.
Equity
305,566 kr.
Total Assets
573,964 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-625 t.280 t.306 t.1
2016--28 t.-48 t.26 t.-
2015-255 t.-154 t.73 t.-
2014-1.3 mio.-237 t.227 t.-
2013-892 t.54 t.464 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMA EVIDENCE ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

PHARMA EVIDENCE ApS: The 2016 annual report is outApr 4, 2017

PHARMA EVIDENCE ApS has published its annual report for 2016. Gross profit came to DKK -28,318, and the net result was DKK -47,525.

About PHARMA EVIDENCE ApS

PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees. In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity amounted to DKK 134,401.